SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (17644)1/11/1999 1:09:00 PM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
Vlad... The ACC article is on the WEB

see pages 273-282 USE of Sildenafil (Viagra) in patients with cardiovascular disease

cardiosource.com



To: VLAD who wrote (17644)1/11/1999 2:18:00 PM
From: MythMan  Respond to of 23519
 
heck everyone knows they are crooks. What we really need is to get co to change name to vvus.com.

stock would be in triple digits in 3-5 trading days.



To: VLAD who wrote (17644)1/11/1999 2:18:00 PM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
vlad...trivia from the ACC report

ED is a common problem that effects between 10-30 million in the US.

***Viagra is potentially contraindicated in as many as 6 million patients in the US.....

Looks like a large target market audience for MUSE.
In addition to those patients that Viagra does not work on.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News